As you may already know that the government of Canada has extended the suspension of direct flights from India to Canada until September 26, 2021.
After the restriction on direct flights expires, fully vaccinated passengers, and exceptionally unvaccinated passengers eligible to enter Canada, travelling on those flights will need to:
- Obtain a pre-departure negative COVID-19 molecular test result from the Genestrings Laboratory, located above the metro station in the Airport Connect Building (ACB) at the Indira Gandhi International Airport.
- Perform this test within 18 hours before their scheduled departure.
- Present the test report with a QR code issued by this laboratory to the air operator before boarding.
Alternatively, travellers who have previously tested positive for COVID-19 can present a positive molecular test issued by a certified laboratory in India. The date of the collection must have been between 14 and 180 days before their scheduled departure to Canada.
Airlines will refuse boarding to any traveller who’s unable to meet these requirements.
Passengers who travel from India to Canada via an indirect route still need to provide a pre-departure negative COVID-19 molecular test result from a third country before continuing their journey to Canada.
Keep In Mind
- Certain countries don’t allow entry or transit of passengers arriving from India or of passengers who have previously tested positive for COVID-19.
- COVID-19 testing for passengers in transit might not be available in all international airports or third countries.
- If you test positive during transit, you may face local quarantine regulations or be returned to your point of departure.
Carefully consider your itinerary, transit options and entry requirements for third countries.
- Book an RT-PCR test at Delhi Airport – Indira Gandhi International Airport
- COVID-19: Travel, testing, quarantine and borders